(EIGR) Eiger Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eiger Biopharmaceuticals | (EIGR) share price targets
Complete technical analysis of Eiger Biopharmaceuticals (EIGR) by charts plus indicators, forecast predictions and share price targets for Eiger Biopharmaceuticals (EIGR)
Eiger Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-01-25 View latest technical analysis
10 day averaged volume of Eiger Biopharmaceuticals is 5230
Date | Daily Closing Price | Open | High | Low | Volume |
25 Thu Jan 2024 | 5.96 | 6.03 | 6.05 | 5.75 | 0.899 times |
24 Wed Jan 2024 | 6.11 | 6.67 | 6.71 | 6.10 | 1.415 times |
23 Tue Jan 2024 | 6.53 | 6.66 | 6.78 | 6.53 | 0.382 times |
22 Mon Jan 2024 | 6.52 | 6.76 | 7.02 | 6.52 | 0.994 times |
19 Fri Jan 2024 | 6.74 | 7.10 | 7.10 | 6.48 | 1.281 times |
18 Thu Jan 2024 | 6.99 | 6.96 | 7.33 | 6.70 | 1.969 times |
17 Wed Jan 2024 | 6.95 | 6.78 | 7.40 | 6.76 | 1.052 times |
16 Tue Jan 2024 | 6.98 | 7.37 | 7.37 | 6.79 | 0.88 times |
12 Fri Jan 2024 | 7.36 | 7.21 | 7.50 | 7.20 | 0.784 times |
12 Fri Jan 2024 | 7.36 | 7.21 | 7.50 | 7.20 | 0.784 times |
My analysis of stock is bullish for shortterm, and stock might move up till 8 or till 11.7. Use a stoploss of 4.9 and if this stock hits its stoploss, then it can fall down till 1.82
Share price targets for Eiger Biopharmaceuticals (EIGR)
Target Type | Value |
Downside Target | 0.20 |
Downside Target | 0.21 |
Downside Target | 0.25 |
Downside Target | 0.27 |
Downside Target | 0.36 |
Downside Target | 0.37 |
Downside Target | 0.48 |
Downside Target | 0.95 |
Downside Target | 5.75 |
Upside Target | 6.20 |
Upside Target | 6.48 |
Upside Target | 7.02 |
Upside Target | 7.20 |
Upside Target | 7.40 |
Upside Target | 7.50 |
Upside Target | 7.92 |
Intraday share price targets for Eiger Biopharmaceuticals (EIGR)
Target Type | Value |
Downside Intraday Target | 5.47 |
Downside Intraday Target | 4.97 |
Upside Intraday Target | 6.74 |
Upside Intraday Target | 7.51 |
Upside Intraday Target | 6.24 |
Weekly technical analysis of Eiger Biopharmaceuticals (EIGR)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Thu Jan 2024 | 5.96 | 6.76 | 7.02 | 5.75 | 0.712 times |
19 Fri Jan 2024 | 6.74 | 7.37 | 7.40 | 6.48 | 6.61 times |
12 Fri Jan 2024 | 7.36 | 7.21 | 7.50 | 7.20 | 0.066 times |
12 Fri Jan 2024 | 7.36 | 6.73 | 7.92 | 6.20 | 0.056 times |
05 Fri Jan 2024 | 0.22 | 0.23 | 0.25 | 0.20 | 1.721 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Eiger Biopharmaceuticals (EIGR)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Thu Jan 2024 | 5.96 | 0.23 | 7.92 | 0.20 | 0.142 times |
29 Fri Dec 2023 | 0.22 | 0.36 | 0.36 | 0.20 | 2.174 times |
30 Thu Nov 2023 | 0.34 | 0.27 | 0.48 | 0.27 | 0.533 times |
31 Tue Oct 2023 | 0.26 | 0.30 | 0.37 | 0.21 | 0.74 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Eiger Biopharmaceuticals (EIGR)
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Eiger Biopharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Eiger Biopharmaceuticals in short term but the sell signal is initial and weak.
Eiger Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Eiger Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Eiger Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.74 and Eiger Biopharmaceuticals (EIGR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eiger Biopharmaceuticals (EIGR) stock. Volume based technical analysis of Eiger Biopharmaceuticals (EIGR) stock is negative.
Eiger Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Eiger Biopharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Eiger Biopharmaceuticals in short term but the sell signal is initial and weak.
Eiger Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Eiger Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Eiger Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.74 and Eiger Biopharmaceuticals (EIGR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eiger Biopharmaceuticals (EIGR) stock. Volume based technical analysis of Eiger Biopharmaceuticals (EIGR) stock is negative.
Eiger Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.